The UK prioritised delivery of the first dose of BNT162b2 (Pfizer/BioNTech) and AZD1222
(AstraZeneca) vaccines by extending the interval between doses up to 12 weeks. In 750 …

Data about the long-term duration of antibodies after SARS-CoV-2 vaccination are still
scarce and are important to design vaccination strategies. In this study, 231 healthcare …

Assessment of T-cell responses to severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) antigens may be of value to determine long-lasting protection to breakthrough …

Objectives Vaccination against SARS-CoV-2 has been extensively deployed during COVID-
19 pandemic. One efficient method to evaluate response to vaccination is the assessment of …

The potential impact of disease-modifying therapies (DMTs) for multiple sclerosis (MS) on
COVID-19 vaccination is poorly understood. According to recent observations, the humoral …

Treatment with rituximab (RTX) blunts SARS-CoV-2 vaccination-induced humoral response.
We sought to identify predictors of a positive immunogenic response to the BNT162b2 …

Background Innate immunity, armed with pattern recognition receptors including Toll-like
receptors (TLR), is critical for immune cell activation and the connection to anti-microbial …

In 2020, we reported a low seroprevalence of N-specific antibodies in 4147 health care
workers (HCWs) at a frontline hospital in Tokyo, Japan. In Japan, a vaccine campaign was …

In this paper, we present a systematic review and meta-analysis that aims to evaluate the
reliability of coronavirus disease diagnostic tests in 2019 (COVID-19). This article seeks to …

This study aimed to evaluate the correlation between in-house and commercial binding-
specific IgG antibodies and between in-house and commercial SARS-CoV-2 surrogate virus …